[Long-term treatment of chronic urinary tract infections with the combination drug trimethoprim-sulfamethoxazol (Eusaprim) in chronic patients].
D000328:Adult; D000368:Aged; D000892:Anti-Infective Agents, Urinary / Q000627:therapeutic use*; D002908:Chronic Disease; D004338:Drug Combinations; D004352:Drug Resistance, Microbial; D004755:Enterobacteriaceae / Q000187:drug effects; D004926:Escherichia coli / Q000187:drug effects; D005260:Female; D006801:Humans; D007709:Klebsiella / Q000187:drug effects; D008134:Long-Term Care; D008297:Male; D008875:Middle Aged; D011511:Proteus / Q000187:drug effects; D011549:Pseudomonas / Q000187:drug effects; D013210:Staphylococcus / Q000187:drug effects; D013420:Sulfamethoxazole / Q000627:therapeutic use*; D014295:Trimethoprim / Q000627:therapeutic use*; D014546:Urinary Catheterization; D014552:Urinary Tract Infections / Q000188:drug therapy* / Q000382:microbiology
D000892:Anti-Infective Agents, Urinary; D004338:Drug Combinations; D014295:Trimethoprim; D013420:Sulfamethoxazole
Die Langzeitbehandlung chronischer Harnwegsinfektionen mit dem Kombinationspräparat Trimethoprim-Sulfamethoxazol (Eusaprim) bei chronisch Kranken